breath analysis

R&D

It has been estimated that 12% of the UK population suffer from irritable bowel syndrome (IBS), an umbrella term that describes a bro

Oncology

Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.